Insider Shareholders with Direct Ownership of Akoya Biosciences, Inc. (AKYA)
This section provides a comprehensive overview of the insiders with direct ownership of Akoya Biosciences, Inc. (AKYA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akoya Biosciences, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Garry Ph.D. Nolan
Director |
0 | 88,206 | 591,978 $763,651 | 11 |
Dec 02, 2022
Reduced 0.19%
|
Joseph Driscoll
Chief Financial Officer |
287,113 | 24,613 | 262,500 $338,625 | 4 |
Dec 22, 2022
Added 48.78%
|
282,500 | 282,500 | 248,202 $320,180 | 7 |
Apr 01, 2025
Reduced 6.21%
|
|
Frederic Pla
Chief Operating Officer |
107,500 | 6,000 | 101,500 $130,935 | 7 |
Mar 23, 2024
Reduced 1.94%
|
Robert G Shepler
Director |
35,000 | 0 | 35,000 $45,150 | 1 |
Nov 18, 2021
Added 36.36%
|
Marilee Moy
CHIEF PEOPLE OFFICER |
20,000 | 0 | 20,000 $25,800 | 1 |
Feb 23, 2023
Added 50.0%
|
Ehab El Gabry
Chief Medical Officer |
16,250 | 0 | 16,250 $20,962 | 1 |
Feb 23, 2023
Added 50.0%
|
Brian Mc Kelligon
President and CEO |
1,260,678 | 1,270,227 | 0 $0 | 34 |
Jul 08, 2025
Reduced 100.0%
|
Goldman Myla Lai
Director |
20,000 | 20,000 | 0 $0 | 2 |
Jul 08, 2025
Reduced 100.0%
|
Matthew Winkler
Director |
203,388 | 984,513 | 0 $0 | 2 |
Jul 08, 2025
Reduced 100.0%
|
Scott Mendel
Director |
28,500 | 28,500 | 0 $0 | 3 |
Jul 08, 2025
Reduced 100.0%
|
Niro Ph.D Ramachandran
Chief Business Officer |
364,246 | 339,173 | 0 $0 | 15 |
Jul 08, 2025
Reduced 100.0%
|
Jennifer Kamocsay
Chief Legal Officer |
190,000 | 190,000 | 0 $0 | 7 |
Jul 08, 2025
Reduced 100.0%
|
Pascal Bamford
Chief Clinical Officer |
127,500 | 210,258 | 0 $0 | 5 |
Jul 08, 2025
Reduced 100.0%
|